These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9676539)

  • 1. Prostate cryoablation: update 1998.
    Schmidt JD; Doyle J; Larison S
    CA Cancer J Clin; 1998; 48(4):239-53. PubMed ID: 9676539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
    Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
    Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
    Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
    Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
    Ng CK; Moussa M; Downey DB; Chin JL
    J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryoablation of prostate cancer].
    Witzsch UK; Skriapas K; Becht E
    Urologe A; 2008 Apr; 47(4):449-54. PubMed ID: 18351318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
    Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
    BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for cryoablation of the prostate in the management of localized prostate carcinoma?
    Long JP
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):675-90. PubMed ID: 8773504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience.
    Ellis DS
    Urology; 2002 Aug; 60(2 Suppl 1):34-9. PubMed ID: 12206846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).
    Chin JL; Al-Zahrani AA; Autran-Gomez AM; Williams AK; Bauman G
    J Urol; 2012 Oct; 188(4):1170-5. PubMed ID: 22901586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
    Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
    J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.
    Siddiqui KM; Billia M; Al-Zahrani A; Williams A; Goodman C; Arifin A; Violette P; Bauman G; Chin JL
    J Urol; 2016 Oct; 196(4):1105-11. PubMed ID: 27157372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results.
    Wieder J; Schmidt JD; Casola G; vanSonnenberg E; Stainken BF; Parsons CL
    J Urol; 1995 Aug; 154(2 Pt 1):435-41. PubMed ID: 7541861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
    De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
    BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
    Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
    Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
    Barzell WE; Melamed MR
    Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.